Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medicine|July 9, 2025
Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumorsRuhper Cekin, Didar Senocak, Sener Cihan
Experimental and Therapeutic Medicine|April 3, 2026
Prior curative-intent treatment strategy affects progression outcomes of first-line immunotherapy in metastatic non-small cell lung cancer: A retrospective cohort studyRuhper Cekin, Didar Senocak, Serdar Arici, et al.
Current Problems in Cancer|June 16, 2019
The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapySerdar Arici, Caglayan Geredeli, Saban Secmeler, et al.
Oncology Research and Treatment|November 26, 2020
Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?Serdar Arici, Abdullah Sakin, Ruhper Cekin, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|April 22, 2016
Single Gallstone Associated with High Fasting Insulin LevelCan Oner, Sibel Yilmaz-Oner, Ruhper Cekin, et al.
Oncology Research and Treatment|June 23, 2020
The Clinical Importance of Androgen Receptor Status in Response to Neoadjuvant Chemotherapy in Turkish Patients with Local and Locally Advanced Breast CancerSerdar Arici, Selma Sengiz Erhan, Caglayan Geredeli, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 21, 2020
The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancerSerdar Arici, Sevda S Karyagar, Savas Karyagar, et al.
Indian Journal of Cancer|February 17, 2025
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcomeMuhammed M Atci, Saban Secmeler, Abdullah Sakin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 1, 2020
The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatmentSerdar Arici, Jamshid Hamdard, Abdullah Sakin, et al.
Current Problems in Cancer|May 12, 2024
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancerYasin Kutlu, Ruhper Cekin, Sabin Goktas Aydin, et al.
Pageof 1